Take the Trip Out of Psychedelics?

In an essay published in International Journal of Drug Policy, Dutch psychology researcher Julian Heller and philosopher Yogi Hendlin argue that such attempts to take the trip out of psychedelics are a mistake.

The duo explain that psychedelics’ therapeutic potential is not merely neurochemical, but “highly dependent on subjective experience and environmental context.”

Read more

FDA Approval of Psychedelics, Coming Soon?

A recent report from the Substance Abuse and Mental Health Services Administration (SAMHSA) encourages U.S. states to begin preparing for possible approval of psychedelic therapies by the Food and Drug Administration.

The transition from research to clinics is moving faster than those in the field anticipated even five years ago, the report notes, and being proactive is important.

“The question is not whether individuals in a particular state will use psychedelics, but whether they will do so in regulated, safe contexts or in underground networks,” the report reads.

Read more